Package Leaflet: Information for the Patient
Tramadol/Dexketoprofen Krka 75 mg/25 mg Film-Coated Tablets EFG
tramadol hydrochloride/dexketoprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Tramadol/Dexketoprofen Krka contains the active substances tramadol hydrochloride and dexketoprofen. Tramadol hydrochloride is a pain reliever belonging to the group of opioids that act on the central nervous system. It relieves pain by acting on specific nerve cells in the brain and spinal cord.
Dexketoprofen is a pain reliever belonging to the group of non-steroidal anti-inflammatory drugs (NSAIDs).
Tramadol/dexketoprofen is used for the symptomatic treatment of short-term moderate to severe acute pain in adults.
You should consult a doctor if you do not feel better or if you get worse.
Do not takeTramadol/Dexketoprofen Krka
Warnings and precautions
Consult your doctor before starting to take this medicine:
Tramadol can cause physical and psychological dependence. When this medicine is taken for a prolonged period, its effect may decrease, and higher doses may be necessary (development of tolerance). In patients with a tendency to abuse medicines or those with drug dependence, treatment with tramadol/dexketoprofen should only be carried out for short periods and under strict medical control. Inform your doctor if any of these problems appear during treatment with tramadol/dexketoprofen or if they appeared in the past.
Talk to your doctor if you experience any of the following symptoms while taking tramadol/dexketoprofen: extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. This may indicate that you have adrenal insufficiency (low cortisol levels). If you present any of these symptoms, inform your doctor, he will decide if you should take a hormonal supplement.
Tramadol is transformed in the liver by an enzyme. Some people have a variation of this enzyme, and this can affect each person differently. In some people, sufficient pain relief may not be achieved, while others are more likely to suffer from serious side effects. If you notice any of the following side effects, you should stop taking this medicine and consult a doctor immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, general malaise, or vomiting, constipation, loss of appetite.
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol alone. Consult your doctor immediately if you present any of the symptoms related to this serious syndrome (see section 4 "Possible side effects").
Respiratory disorders related to sleep
Tramadol/dexketoprofen may cause sleep-related respiratory disorders such as central sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). These symptoms can be pauses in breathing during sleep, nocturnal awakening due to difficulty breathing, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else observes these symptoms, consult your doctor. Your doctor may consider reducing the dose.
Infections
Tramadol/dexketoprofen may mask the signs of an infection, such as fever or pain. Consequently, tramadol/dexketoprofen may delay the appropriate treatment of the infection, which can increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while you have an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
During chickenpox, it is recommended to avoid using this medicine.
Children and adolescents
This medicine has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and the medicine should not be used in children or adolescents.
Use in children with respiratory problems
The use of tramadol is not recommended in children with respiratory problems, as the symptoms of tramadol toxicity can worsen in these children.
Other medicines and Tramadol/Dexketoprofen Krka
Tell your doctor if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. There are some medicines that should not be taken together, and others that may require a dose adjustment if taken together.
Always inform your doctor if, in addition to tramadol/dexketoprofen, you are taking any of the following medicines:
The use oftramadol/dexketoprofenis not recommended with:
The use oftramadol/dexketoprofenrequires caution with:
The use oftramadol/dexketoprofenshould be taken into account with:
The analgesic effect of tramadol may be reduced, and the duration of action decreased if you also take medicines that contain:
The risk of side effects increases:
Taking Tramadol/Dexketoprofen Krka with alcohol
Do not drink alcohol during treatment with tramadol/dexketoprofen, as it may increase the effect of the medicine.
For instructions on how to take Tramadol/Dexketoprofen Krka, see section 3.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Dexketoprofen may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected. From the 20th week of pregnancy, dexketoprofen may cause kidney problems in your fetus, which can cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or constriction of a blood vessel (ductus arteriosus) in the baby's heart.
Tramadol is excreted in breast milk.
The use of tramadol/dexketoprofen is contraindicated in pregnancy and during breastfeeding.
Driving and using machines
Tramadol/dexketoprofen may affect your ability to drive and use machines, as it can cause dizziness, blurred vision, or drowsiness as side effects of treatment. This happens mainly when tramadol/dexketoprofen is taken with medicines that affect mood and emotions or when taken with alcohol.
If you are affected, do not drive or use machines until the symptoms disappear.
Tramadol/Dexketoprofeno Krka contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; i.e. it is essentially "sodium-free".
Use in athletes
Athletes are warned that this medicine contains tramadol, a component that can result in a positive doping test.
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor again.
The effective lowest dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult your doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
The dose of tramadol/dexketoprofen you need may vary, depending on the type, intensity, and duration of the pain. Your doctor will tell you how many tablets to take per day and for how long.
The recommended dose is generally 1 film-coated tablet (corresponding to 75 mg of tramadol hydrochloride and 25 mg of dexketoprofen) every 8 hours, not exceeding 3 film-coated tablets per day (corresponding to 225 mg of tramadol hydrochloride and 75 mg of dexketoprofen) and not exceeding 5 days of treatment.
Use in children and adolescents
Tramadol/dexketoprofen is not suitable for children and adolescents.
Elderly patients
If you are 75 years or older, your doctor may recommend prolonging the dosing interval, as your body may eliminate the medication more slowly.
Patients with severe liver or kidney disease/dialysis:
Patients with severe liver and/or kidney insufficiency should not take tramadol/dexketoprofen.
In case of renal dysfunction, if in your case the insufficiency is mild, your doctor may recommend prolonging the dosing interval.
In case of liver dysfunction, if in your case the insufficiency is mild or moderate, your doctor may recommend prolonging the dosing interval.
Swallow the tablet with a sufficient amount of liquid (preferably with a glass of water). Food delays the absorption of tramadol/dexketoprofen; take the tablet at least 30 minutes before meals for faster action.
The score line is to help break the tablet if you have difficulty swallowing it whole.
If you take more Tramadol/Dexketoprofen Krka than you should
If you have taken too much medication, inform your doctor immediately or go to the emergency department of your nearest hospital or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken. Please remember to always carry the medication package or this leaflet with you.
The symptoms of overdose of this medication are:
If you forget to take Tramadol/Dexketoprofen Krka
Do not take a double dose to make up for forgotten doses. Take the next dose when it is due (according to section 3 "How to take Tramadol/Dexketoprofen Krka").
If you stop treatment with Tramadol/Dexketoprofen Krka
Generally, no after-effects are expected after stopping treatment with tramadol/dexketoprofen.
However, in rare cases, patients who have been taking tramadol/dexketoprofen tablets for some time may feel unwell if they stop taking it suddenly. They may feel agitation, anxiety, nervousness, or tremors, confusion, hyperactivity, have difficulty sleeping, and gastrointestinal or stomach disorders. Rarely, people may suffer from panic attacks, hallucinations, delirium, paranoia, or feel a loss of identity. They may experience unusual perceptions such as itching, tingling, and numbness, ringing in the ears (tinnitus). Very rarely, other unusual symptoms such as confusion, delirium, feeling of being detached from oneself (depersonalization), change in perception of reality (derealization), illusions of persecution (paranoia) have been observed. Please consult your doctor if you experience any of these effects after stopping tramadol/dexketoprofen.
If you have any other questions about the use of this medication, ask your doctor.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Possible side effects are listed below according to their likelihood of occurrence.
You should see a doctor immediately if you experience symptoms of an allergic reaction such as swelling of the face, tongue, and/or throat, and/or difficulty swallowing or urticaria along with difficulty breathing.
Stop using tramadol/dexketoprofen if you experience a skin rash, or any lesion inside the mouth or on the mucous membranes, or any sign of allergy.
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Psychological side effects may appear after treatment with tramadol/dexketoprofen. The intensity and nature of these may change (depending on the patient's personality and treatment duration):
Cases of worsening asthma have been reported.
Withdrawal symptoms may appear when treatment is stopped suddenly (see "If you stop treatment with Tramadol/Dexketoprofen Krka").
Cases of seizures have been reported, mainly when administering high doses of tramadol or when tramadol is taken together with other medications that may cause them.
Very rare(may affect up to 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
Tell your doctor immediately if you notice any gastrointestinal side effects at the start of treatment (e.g., stomach pain or burning, or bleeding), if you have previously suffered from these side effects due to prolonged treatment with anti-inflammatory medications, and especially if you are an elderly patient.
The most common side effects during treatment with tramadol/dexketoprofen are nausea and dizziness, which affect more than 1 in 10 patients.
During treatment with NSAIDs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medications like tramadol/dexketoprofen may be associated with a small increased risk of suffering a heart attack or stroke.
In patients with immune system disorders affecting connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory medications can rarely cause fever, headache, and neck stiffness.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature.
Keep in the original packaging to protect from light and moisture.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Tramadol/Dexketoprofen Krka
Appearance of the product and packaging content
The tablets are white or almost white, oval, biconvex, film-coated, scored on one side of the tablet, and marked with a K on the other side. Tablet dimensions: approximately 13 mm x 8 mm.
The score line is only to help break the tablet and facilitate swallowing, but not to divide into equal doses.
Tramadol/Dexketoprofen Krka is available in packages of:
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
KRKA, d.d., Novo mesto,
Šmarješka cesta 6, 8501 Novo mesto,
Slovenia
You can request more information about this medication from the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L.,
Calle de Anabel Segura 10, 28108 Alcobendas, Madrid,
Spain
This medication is authorized in the member states of the European Economic Area under the following names:
Member state | Medication name |
Germany | Tradexdolor 75 mg/25 mg film-coated tablets |
Bulgaria | Delxor 75 mg/25 mg film-coated tablets, ???????? 75 mg/25 mg ????????? ???????? |
Cyprus | Tramadol/dexketoprofen TAD 75 mg/25 mg ?????????? ?????? ??????? |
Croatia | Delxora 75 mg/25 mg film-coated tablets |
Slovakia | Delanxara 75 mg/25 mg film-coated tablets |
Slovenia | Tradexera 75 mg/25 mg film-coated tablets |
Spain | Tramadol/Dexketoprofeno Krka 75 mg/25 mg film-coated tablets EFG |
Estonia | Tradexera |
Hungary | Delanxara 75 mg/25 mg film-coated tablets |
Latvia | Tradexera 75 mg/25 mg film-coated tablets |
Lithuania | Tradexera 75 mg/25 mg film-coated tablets |
Czech Republic | Delanxara |
Poland | Delanxara |
Portugal | Tramadol + Dexketoprofen Krka |
Romania | Delxora 75 mg/25 mg film-coated tablets |
Date of the last revision of this leaflet:January 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/